| Literature DB >> 19945889 |
Dale I Godfrey1, Daniel G Pellicci, Onisha Patel, Lars Kjer-Nielsen, James McCluskey, Jamie Rossjohn.
Abstract
alphabeta T cell receptors (TCRs) have traditionally been viewed as receptors for peptide antigens presented by either Major Histocompatibility Complex (MHC) class I (for CD8 T cells) or MHC class II (for CD4 T cells) antigen-presenting molecules. However, it is now clear that some T cell lineages express TCRs that are specialized for recognition of lipid-based antigens presented by the MHC class I-like CD1 family. Recently, the molecular basis for the TCR recognition of glycolipid antigens presented by CD1d has revealed an evolutionarily conserved-docking mode that is distinct from that of peptide-based recognition. T cells carrying these receptors follow a unique developmental pathway that results not only in unconventional antigen specificity, but also seemingly exaggerated functional capabilities, which makes these cells and their antigens highly attractive targets for immunotherapeutic manipulation.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19945889 DOI: 10.1016/j.smim.2009.10.004
Source DB: PubMed Journal: Semin Immunol ISSN: 1044-5323 Impact factor: 11.130